ABSTRACT
Introduction Intracranial saccular aneurysms, if untreated, carry a high risk of morbidity and mortality from intracranial bleeding. Embolization coils are the most common treatment. We describe the periprocedural safety and performance of the initial human experience with the next generation Medina Coil System. Methods The Medina Coil System is a layered threedimensional coil made from a radiopaque, shape set core wire, and shape memory alloy outer coil filaments. Nine aneurysms in five patients were selected for treatment with the Medina Coil System. Results Nine aneurysms in five patients, ranging from 5 to 17 mm in size in various locations, were treated with the Medina Coil System. No procedural or periprocedural complications were encountered. Procedure times, number of coils used to treat the aneurysm, and use of adjunctive devices were much less than anticipated if conventional coil technology had been used. Conclusions The Medina Coil System is a next generation coil that combines all of the familiar and expected procedural safety and technique concepts associated with conventional coils. We found improved circumferential aneurysm filling, which may lead to improved long term outcomes, with fewer devices and faster operating times.
BACKGROUND
Endovascular coiling of cerebral aneurysms has become widely accepted as a safe and effective alternative to surgical clipping of cerebral aneurysms. [1] [2] [3] [4] Advancements in technology, such as trackable balloons, self expanding stents, and flow diverters, allow endovascular treatment of most cerebral aneurysms. [5] [6] [7] [8] [9] [10] [11] However, aneurysm residuals or recanalization remains a challenge. To this end, continued effort must be made to advance coil technology in order to improve long term occlusion rates.
The Medina Coil was designed as a next generation coil technology that incorporates the versatility, technical performance, and safety profile of coils with excellent filling capabilities and, hopefully, more robust long term occlusion rates. This report details the initial clinical experience with this next generation three-dimensional coil in order to assess the immediate periprocedural safety in the treatment of cerebral aneurysms.
MATERIALS AND METHODS Device description
The Medina Coil has been granted CE Mark clearance from the European Union notified body, and is designed to treat all saccular aneurysms of any morphology or location. The Medina Coil is a three-dimensional coil made from a radiopaque, shape set core wire, and shape memory alloy outer filaments that are shaped into petals. The petals lie along the axis of the structure. When deployed, the Medina Coil begins in a linear configuration and then deforms to fill space within the aneurysm. In its unconstrained state, the device retains a linear form with the petals unfolding into a wave form pattern, as shown in figure 1 . But, as the device is introduced into an aneurysm, it bends on itself and deforms to both cover the aneurysm ostium as well as to create a stable structure, while still allowing contrast flow for visualization. The Medina Coil is detachable and is manipulated and deployed through a microcatheter. Similar to conventional coils, it can be retracted and repositioned or removed completely, as desired. The threedimensional petals that constitute the coil surrounding filaments form broader 'loops' rather than thinner wires, as with conventional coils, which allows for stable anchoring of the coil within the aneurysm sac. Mechanically, these broad petals broadly distribute the forces exerted on the aneurysm wall. The Medina Coil line constitutes both framing and filler coils. The framing coils provide support and complex into an outer basket. The filler coils are softer, and are designed to fill the internal space within the framing coils.
Procedure
Patients were selected based on aneurysm size of at least 5 mm in diameter, as the smallest currently available device is 5 mm in diameter. Standard endovascular coiling techniques were used. Briefly, a 6 F groin sheath was used in the groin to allow a 6 F guide catheter to be placed into the distal cervical vertebral or carotid artery. Patients were heparinized with 5000 units, and no one received antiplatelet agents prior to surgery. A 0.021 inch Prowler (Codman, Nadick, Massachusetts, USA) or 0.021 inch Rebar (Micro Therapeutics, Irvine, California, USA) microcatheter was then used to selectively catheterize the target aneurysm. A Medina Framing Coil was chosen using sizing selection in the same manner as choosing traditional coils. If the deployed coil configuration was felt to be unacceptable at any point during the deployment, the coil could always be retracted and redeployed, consistent with current conventional coils. Once adequate placement was confirmed, the coil was mechanically detached. Subsequent coils were then sequentially Open Access Scan to access more free content placed until placement of further coils was not possible or felt to be unnecessary. Procedure time was defined as the length of time that the microcatheter was present in the aneurysm.
Outcomes
Angiographic outcomes were classified by per cent filling. Clinical outcomes were documented at discharge by the patients' primary treating physician (OM).
RESULTS
Nine aneurysms in five patients were treated with the Medina Coil System. Aneurysm locations were middle cerebral (n=3), anterior communicating (n=2), basilar apex, carotid terminus, ophthalmic, posterior communicating, and pericallosal arteries (table 1). All aneurysms were wide necked with a neck to dome ratio >2:1. All aneurysms were treated electively, although one patient had suffered a subarachnoid hemorrhage 1 month prior to treatment and one other patient had bled a year prior to treatment. All aneurysms were treated with Medina Coils alone, except for one case in which a remaining filling segment at the aneurysm base was too small to accommodate a 5 mm filling coil, and therefore a traditional coil was used. All cases were performed without any technical or procedural complications. No periprocedural or postprocedure related clinical complications, such as stroke or aneurysm bleeding, were encountered. Acute residual contrast filling within the coil loops was present in all cases except one, where the final device implanted was a conventional coil. One aneurysm treated was a 6 mm wide necked middle cerebral artery bifurcation aneurysm residual 1 month after surgical clipping. One aneurysm was treated with an Enterprise stent. Procedure time was recorded from the first coil introduced into the microcatheter to the last coil detached. 
Illustrative cases Aneurysm No 3
A patient with multiple intracranial aneurysms presented for elective endovascular treatment of his aneurysms. The aneurysm at the carotid terminus measured 5.2 mm×4.9 mm with a broad neck (figure 2). The aneurysm was treated with a single 6 mm Medina Framing Coil through a Prowler plus microcatheter with a 9 min procedure time. Control angiography demonstrated significant contrast flow within the coil loops, but apparent stagnation in flow. The patient was discharged home the following day without neurologic complaint. Follow-up angiogram at 1 month was performed during workup to address the patient's remaining cerebral aneurysms. Follow-up angiogram demonstrated >95% occlusion of the aneurysm with a small neck residual, which was present immediately postprocedure and remained stable in size.
Aneurysm No 9
This patient experienced a subarachnoid hemorrhage 1 month previously from a 17 mm×9 mm with 5.5 mm neck left anterior communicating region aneurysm ( figures 3 and 4 ). An 8 mm Medina Framing Coil was used to secure the dome of the aneurysm. A second 7 mm Median Framing Coil was complexed with the first coil and used to create a proximal basket covering the aneurysm ostium. Complexing framing coils to create a larger or longer coil mass is a common endovascular strategy for oblong and narrow aneurysms or when the aneurysm is much larger than the available coils. The remaining unfilled coil volume within the framing basket was subsequently filled with a 6 mm Medina Filling Coil and then two 5 mm filling coils. The final angiogram showed coils filling the aneurysm with some contrast penetrating the proximal coil mass, and the patency of the parent anterior cerebral and anterior communicating arteries and their distal branches. The patient was discharged home the following day without any neurologic complaints.
DISCUSSION
Wide necked medium and large sized aneurysms remain a common but challenging group of aneurysms in which to effect successful endovascular treatment. Adjunctive devices such as balloons and stents are often required to achieve acceptable endovascular results, but these techniques have been reported to carry a higher risk. 5 Our early human experience with the Medina Coil, a next generation coil system, demonstrates the familiar coil ease of use methods and periprocedural safety. Additionally, we experienced relatively short procedure times while utilizing few adjunctive technologies.
The reported incidence of residual aneurysm necks after surgical clipping ranges from 3.8% to 18%. 12 Even after complete surgical clipping of an aneurysm, regrowth is thought to occur in up to 15% and rerupture in 2.7% of patients. 13 14 A large endovascular series demonstrated recanalization rates as high as 42% in small aneurysms with wide necks. 15 Large and giant aneurysms demonstrated much higher recanalization rates of 87% and 90%. 15 These limitations continue to drive innovation of new devices, such as flow diverters and bioactive coils. 3 4 10 The Medina Coil is, very simply, an advanced coil technology that has some useful similarities with conventional coils, such as device size selection with framers and fillers. The final deployed device construct takes advantage of its surrounding filament design to provide improved volumetric filling of the aneurysm, and to hopefully result in better long term occlusion rates. At this early point of device use, the long term implications are unclear, but the early successful use of the technology in a safe manner consistent with current coil technology is extremely encouraging. To date, three of the Medina treated aneurysms have reached a point at which follow-up angiography was possible. All three demonstrated >95% aneurysm occlusion. This limited angiographic follow-up provides an early indication that, like many traditional coils, this device progressively occludes aneurysms over time. These results are particularly exciting given the relative complexity of the aneurysms treated to date. In our experience, aneurysms treated with conventional coils tend to require about one coil per millimeter in length of the largest aneurysm dimension. Additionally, we feel that the operative risk associated with placement of conventional coils increases as the number of coils placed increases. The Medina Coil was able to treat medium and large aneurysms with fewer coils than we thought would be expected if using conventional coils. An advantage of the Medina Coil design is that it places broader loops at the aneurysm neck that contain future coil loops, minimizing herniation or prolapse into the parent artery. Anecdotally, this seems to improve the safety of placing subsequent coils into the aneurysm. The Medina Coil design was associated with very fast procedure times, with several aneurysms treated in <10 min.
There are limitations to this report, most significantly that it is a single center, operator adjudicated study. However, the early periprocedural safety of the Medina Coil appears to be well demonstrated. As more delayed angiographic data become available, and larger numbers of aneurysms receive treatment with the Medina Coil, it is possible that this technology will represent a major step forward in endovascular coil embolization of cerebral aneurysms.
CONCLUSION
The Medina Coil System is a next generation coil that combines the familiar procedural safety and technique concepts associated with conventional coils with improved circumferential aneurysm filling, which it is thought will lead to improved long term outcomes. However, the data presented here demonstrate that, at a minimum, the Medina Coil System can be used safely to effect aneurysm embolization and that, in human cases, it functions in a manner consistent with current conventional coil technology.
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